Publication Details
Publication: Health Industry Distribution Newspaper (健康産業流通新聞), No. 1161, Pet Supplement Special Feature
Publication Date: May 28, 2026
Original Language: Japanese
English Translation of the Published Article
Note: The following English text is a faithful rendering of the information presented in the original Japanese media article. The content reflects the original media coverage.
Outdoor-cultivated Agaricus KA21 was featured in a pet supplement special issue of Health Industry Distribution Newspaper. The article reports that Toei Shinyaku has supplied KA21 products to veterinarians and animal hospitals for approximately ten years.
The feature introduces the company’s veterinary research, including work involving dogs with Malassezia-associated skin and ear conditions. The article describes the use of KA21 in a clinical setting and refers to changes observed during the study period, together with research on anti-beta-glucan antibodies.
The article also notes Toei Shinyaku’s continuing collaboration with veterinary professionals and academic researchers. These activities have contributed to the development of scientific information specifically relevant to companion animals.
The coverage positions the pet field as an established application area for KA21, supported by years of supply to veterinary channels and the accumulation of research data.
日本語記事概要 / Japanese Summary
健康産業流通新聞2026年5月28日号「ペットサプリ」特集で、露地栽培アガリクスKA21が紹介されました。記事では、約10年にわたる獣医師・動物病院への供給実績や、犬のマラセチアに関連する研究、抗β-グルカン抗体に関する検討など、ペット分野での研究・活用実績が取り上げられています。